Genus (GNS) Receives Buy Rating from Peel Hunt

Peel Hunt reaffirmed their buy rating on shares of Genus (LON:GNS) in a research note released on Wednesday, November 15th. They currently have a GBX 2,600 ($34.99) target price on the stock.

GNS has been the topic of a number of other research reports. N+1 Singer upgraded shares of Genus to a buy rating and boosted their target price for the company from GBX 1,844 ($24.82) to GBX 2,485 ($33.45) in a research report on Monday, October 30th. Kepler Capital Markets initiated coverage on shares of Genus in a research report on Tuesday, November 7th. They set a hold rating and a GBX 2,353 ($31.67) target price on the stock. Liberum Capital restated a buy rating and set a GBX 1,950 ($26.24) price objective on shares of Genus in a report on Thursday, August 24th. Finally, Numis Securities restated a hold rating and set a GBX 1,815 ($24.43) price objective on shares of Genus in a report on Thursday, September 7th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of Hold and an average target price of GBX 2,270.60 ($30.56).

Genus (LON:GNS) traded up GBX 11 ($0.15) during trading on Wednesday, hitting GBX 2,339 ($31.48). 39,210 shares of the company were exchanged, compared to its average volume of 58,851. Genus has a 52 week low of GBX 1,652 ($22.23) and a 52 week high of GBX 2,500 ($33.65).

The firm also recently disclosed a dividend, which was paid on Friday, December 1st. Shareholders of record on Thursday, November 16th were issued a dividend of GBX 16.20 ($0.22) per share. The ex-dividend date of this dividend was Thursday, November 16th. This is an increase from Genus’s previous dividend of $7.40. This represents a yield of 0.83%.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Week Herald and is the property of of Week Herald. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at

Genus Company Profile

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with's FREE daily email newsletter.

Leave a Reply